Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
Zhe Yang, Jingqi Sun, Li Zhuang, Haibo Mou, Shusen Zheng – 27 January 2022
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation
Mariana C. Zapata, Mark R. Pedersen – 27 January 2022
NASH and the Gut Microbiome: Implications for New Therapies
Cynthia J. Tsay, Joseph K. Lim – 27 January 2022
Reply
Najib Ben Khaled, Daniel Rössler, Florian P. Reiter, Julia Mayerle, Christian M. Lange, Max Seidensticker, Markus Guba, Enrico N. De Toni – 27 January 2022
Epidemiology of Liver Diseases in India
Dipankar Mondal, Kausik Das, Abhijit Chowdhury – 27 January 2022
A Primer to the Diagnostic and Clinical Utility of Spleen Stiffness Measurement in Patients With Chronic Liver Disease
Andrea Mladenovic, Raj Vuppalanchi, Archita P. Desai – 27 January 2022
The Patient Perspective on Telemedicine
Karen Hoyt, Andrew Reynolds – 27 January 2022
Introduction: The Role of Liver Transplantation in Acute‐on‐Chronic Liver Failure
Vinay Sundaram – 27 January 2022
Liver Transplantation in Mexico
Maximiliano Servin‐Rojas, Antonio Olivas‐Martinez, Liz Toapanta‐Yanchapaxi, Ignacio García‐Juárez – 27 January 2022
Blood Pressure Variability in Liver Transplant Recipients: The Who, What, When, and How
Jeremy Louissaint, Brett E. Fortune – 27 January 2022